UAB Shapropharma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
- |
- |
0 |
0 |
0 |
0 |
2023 |
---|
0 |
0 |
-2,563 |
-2,563 |
-2,563 |
- |
-1.77 |
- |
- |
-1,563 |
2,766 |
0 |
1,166 |
2024 |
---|
37,503 |
37,503 |
-1,452 |
-1,452 |
-1,452 |
0.80 |
-13.72 |
23.63 |
-3.87 |
-3,015 |
41,379 |
0 |
38,235 |
Register and
explore Okredo data2024 |
---|
37,503 |
37,503 |
-1,452 |
-1,452 |
-1,452 |
0.80 |
-13.72 |
23.63 |
-3.87 |
-3,015 |
41,379 |
0 |
38,235 |
Register and
explore Okredo data2024
Turnover (€)
37,503 €- *
Sales per employee (€)
37,503 €- *
Profit before tax (€)
-1,452 €43 % *
Net Profit (€)
-1,452 €43 % *
Profit per employee (€)
-1,452 €43 % *
Working capital requirement
0.80 - *
Debt-to-equity ratio
-13.72 -675.14 % *
Total profitability (%)
23.63 %- *
Net profitability (%)
-3.87 %- *
Equity (€)
-3,015 €-93 % *
Amounts Payable And Liabilities (€)
41,379 €1,396 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
38,235 €3,179 % *